ICRA has assigned an IPO Grade 1 to the proposed initial public offering of Saamya Biotech (India) Limited (SBIL). The grading assigned reflects the inherently high-risk associated with execution of Greenfield projects in the emerging biotechnology space.The promoters although qualified in the field of medicine, lack experience in the area of drug manufacture.
The risk factors […]